相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of inhibitors for uPAR: blocking the interaction of uPAR with its partners
Cai Yuan et al.
DRUG DISCOVERY TODAY (2021)
Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients
Ulrich Jehn et al.
SCIENTIFIC REPORTS (2021)
The Urokinase Receptor (uPAR) as a Trojan Horse in Targeted Cancer Therapy: Challenges and Opportunities
Virginia Metrangolo et al.
CANCERS (2021)
suPAR, a Circulating Kidney Disease Factor
Changli Wei et al.
FRONTIERS IN MEDICINE (2021)
Biomarkers in COVID-19: An Up-To-Date Review
Madhusudan Samprathi et al.
FRONTIERS IN PEDIATRICS (2021)
Evaluation of the relationship between KIM-1 and suPAR levels and clinical severity in COVID-19 patients: A different perspective on suPAR
Bugra Kerget et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD Progression in Children
Darcy K. Weidemann et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
Francisco Alejandro Lagunas-Rangel
JOURNAL OF MEDICAL VIROLOGY (2020)
Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients
Athanasios Chalkias et al.
MOLECULAR DIAGNOSIS & THERAPY (2020)
COVID-19: An up-to-date review - from morphology to pathogenesis
Amanjit Bal et al.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2020)
Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients
Aijia Ma et al.
CRITICAL CARE (2020)
C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis
Ian Huang et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2020)
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2
Michele Catanzaro et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
Nikoletta Rovina et al.
CRITICAL CARE (2020)
Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
Niaz Mahmood et al.
FRONTIERS IN ONCOLOGY (2018)
suPAR as a marker of infection in acute kidney injury - a prospective observational study
Anna Hall et al.
BMC NEPHROLOGY (2018)
Podocyte Biology and Pathogenesis of Kidney Disease
Jochen Reiser et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Serum Soluble Urokinase-Type Plasminogen Activator Receptor Levels and Idiopathic FSGS in Children: A Single-Center Report
Margret E. Bock et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Integrins in Kidney Disease
Ambra Pozzi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Development of Novel Therapeutics Targeting the Urokinase Plasminogen Activator Receptor (uPAR) and Their Translation Toward the Clinic
Andrew P. Mazar et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Computer Aided Identification of Small Molecules Disrupting uPAR/α5β1-Integrin Interaction: A New Paradigm for Metastasis Prevention
Pratima Chaurasia et al.
PLOS ONE (2009)
The interaction between urokinase receptor and vitronectin in cell adhesion and signalling
Chris D. Madsen et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2008)
Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice:: Inhibitory effects on receptor-mediated uPA activity in vitro and in vivo
Jesper Pass et al.
THROMBOSIS AND HAEMOSTASIS (2007)
Mechanisms of disease: Hereditary proteinuria syndromes and mechanisms of proteinuria
K Tryggvason et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells
JS Rao et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-β
J Kiyan et al.
EMBO JOURNAL (2005)
Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules?
N Montuori et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease
P Iribarren et al.
IMMUNOLOGIC RESEARCH (2005)
Urokinase receptor and integrin interactions
MC Kugler et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
uPAR: A versatile signalling orchestrator
F Blasi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Proteinuria after injection of human focal segmental glomerulosclerosis factor
M Sharma et al.
TRANSPLANTATION (2002)
Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction
T Tarui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Transmission of glomerular permeability factor from a mother to her child
MJ Kemper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
